sorbitol has been researched along with Hyperlipoproteinemia Type II in 2 studies
D-glucitol : The D-enantiomer of glucitol (also known as D-sorbitol).
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uccella, R | 1 |
| Morenghi, R | 1 |
| Agosti, C | 1 |
| Saponati, G | 1 |
| Guida, L | 1 |
| Grimaldi, S | 1 |
| Avella, F | 1 |
| Marullo, L | 1 |
| Mascio, G | 1 |
2 other studies available for sorbitol and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Possible glucagon-mediated hypocholesterolemic activity of a nicotinic acid derivative (sorbinicate).
Topics: Adult; Cholesterol; Glucagon; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Ma | 1983 |
[The use of sorbinicate in the treatment of hyperlipoproteinemia type IIa and IIb].
Topics: Adult; Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle | 1981 |